These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35841803)

  • 1. Response to the letter entitled "Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers".
    Samani A; Krell J; McNeish I; Tookman L
    ESMO Open; 2022 Aug; 7(4):100534. PubMed ID: 35841803
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter comments on: Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.
    Cartwright D; White M; Crearie C; Forte C; Coulter S; Brown J; Randhawa M; Glasspool R; Roxburgh P
    ESMO Open; 2022 Aug; 7(4):100533. PubMed ID: 35870374
    [No Abstract]   [Full Text] [Related]  

  • 3. Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.
    Samani A; Bennett R; Eremeishvili K; Kalofonou F; Whear S; Montes A; Kristeleit R; Krell J; McNeish I; Ghosh S; Tookman L
    ESMO Open; 2022 Apr; 7(2):100401. PubMed ID: 35227967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
    Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.
    Graciano Vera N; Pino Villarreal L; Ureña Vargas J
    Chemotherapy; 2018; 63(3):137-142. PubMed ID: 29768260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault.
    Tsang C; Akbari A; Frechette D; Brown PA
    J Oncol Pharm Pract; 2021 Mar; 27(2):368-375. PubMed ID: 33297846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
    Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
    Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Carboplatin Dosing Based on Estimated GFR.
    Beumer JH; Inker LA; Levey AS
    Am J Kidney Dis; 2018 Feb; 71(2):163-165. PubMed ID: 29217306
    [No Abstract]   [Full Text] [Related]  

  • 10. Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.
    Millward MJ; Webster LK; Toner GC; Bishop JF; Rischin D; Stokes KH; Johnston VK; Hicks R
    Aust N Z J Med; 1996 Jun; 26(3):372-9. PubMed ID: 8811211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
    Morrow A; Garland C; Yang F; De Luna M; Herrington JD
    J Oncol Pharm Pract; 2019 Oct; 25(7):1651-1657. PubMed ID: 30336729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of renal function and its potential impact on carboplatin dosing in children with cancer.
    Chinnaswamy G; Cole M; Boddy AV; Keir M; Price L; Parry A; English M; Veal GJ;
    Br J Cancer; 2008 Sep; 99(6):894-9. PubMed ID: 18781149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to: 'Letter to the editor, European Journal of Cancer', commenting on 'Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma'.
    Shepherd ST; Macpherson IR; White JD; Mark PB
    Eur J Cancer; 2014 Aug; 50(12):2178-9. PubMed ID: 24878064
    [No Abstract]   [Full Text] [Related]  

  • 14. Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function.
    Adamson PC; Veal GJ; Womer RB; Meany HJ; Bernhardt MB; Frazier AL; Balis FM
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27672. PubMed ID: 30767382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin dosing in children: calculation by different formulae.
    Würthwein G; Krefeld B; Gerss J; Boos J
    Onkologie; 2011; 34(1-2):16-22. PubMed ID: 21346380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care.
    McLean L; Whittle JR; Graham J; Ismail H; Lichtenstein M; Hicks RJ; McNally O; Herschtal A; Rosenthal M; Rischin D; Hamilton A
    Gynecol Oncol; 2020 Jun; 157(3):793-798. PubMed ID: 32220419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current dilemmas in carboplatin dosing.
    Ratain MJ
    Clin Adv Hematol Oncol; 2011 Mar; 9(3):237-8. PubMed ID: 21475131
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
    Dooley MJ; Poole SG; Rischin D; Webster LK
    Eur J Cancer; 2002 Jan; 38(1):44-51. PubMed ID: 11750838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formula-based dosing for carboplatin.
    Jodrell DI
    Eur J Cancer; 1999 Sep; 35(9):1299-301. PubMed ID: 10658517
    [No Abstract]   [Full Text] [Related]  

  • 20. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.
    Cathomas R; Klingbiel D; Geldart TR; Mead GM; Ellis S; Wheater M; Simmonds P; Nagaraj N; von Moos R; Fehr M
    Ann Oncol; 2014 Aug; 25(8):1591-7. PubMed ID: 24669017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.